Weiland D E
Maricopa Medical Center, Phoenix, Arizona, USA.
Am J Surg. 1997 Dec;174(6):592-5. doi: 10.1016/s0002-9610(97)00196-7.
Financial pressures from managed care organizations, the government, and other "stakeholders" have resulted in the production of practice guidelines and clinical pathways. Clinical pathways involve all segments of a health care system and may prove to be more beneficial and less hazardous to patients and health care providers.
A historical narrative describing the development of clinical pathways by the Southwestern Surgical Congress (SWSC) and the Southeastern Surgical Congress (SESC) is made. The motivations, the benefits, and the hazards of both clinical pathways and practice guidelines are discussed.
Clinical pathways have proven to reduce length of stay (LOS), complications, and cost, and provide increased patient satisfaction whereas practice guidelines from some specialties show improved quality of care when compared with nonspecialists. However, many practice guidelines are developed by specialists on "best practice" standards, and few have documented studies proving their effectiveness.
Eleven clinical pathways were developed by the SWSC and the SESC and are in the process of revision and study for efficacy. They will be disseminated in the American Surgeon and on the SWSC web site for review and comment. In 1998, both congresses hope to publish the efficacy of selected pathways by describing their effect on LOS and charge for those diagnostic-related groups.
来自管理式医疗组织、政府及其他“利益相关者”的财政压力导致了实践指南和临床路径的产生。临床路径涉及医疗系统的各个环节,可能对患者和医疗服务提供者更有益且危害更小。
撰写一篇历史叙述,描述西南外科大会(SWSC)和东南外科大会(SESC)临床路径的发展情况。讨论临床路径和实践指南的动机、益处及危害。
临床路径已被证明可缩短住院时间(LOS)、减少并发症及降低成本,并提高患者满意度,而某些专科的实践指南与非专科医生相比显示出医疗质量有所改善。然而,许多实践指南是由专科医生根据“最佳实践”标准制定的,很少有文献记载的研究证明其有效性。
SWSC和SESC制定了11条临床路径,目前正在进行修订和疗效研究。这些路径将在美国外科医生杂志及SWSC网站上发布以供审查和评论。1998年,两个大会希望通过描述所选路径对诊断相关组的住院时间和费用的影响来公布其疗效。